Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Antifibrotic Treatment Efficacy in Progressive Pulmonary Fibrosis
2
Mins
October 2024
In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the presence…
Read more
2
Mins
27 Oct 2020
Promising Integrated Care Platform Developed with and Tested by Respiratory Patients: Lessons Learned From the European H2020 CONNECARE Study
In 2014, the European Union (EU) H2020 CONNECARE project was initiated in the Netherlands, Spain, Italy, Germany, Israel, and the UK…
1
Mins
27 Oct 2020
Induction of the Transcriptional Repressor B Lymphocytes-Induced Maturation Protein-1 (Blimp-1) in Lung Cancer
Lung cancer immunotherapy has improved the survival for patients with advanced non-small cell lung cancer (NSCLC)…
2
Mins
14 Nov 2019
Association Between Leukocyte Telomere Length and Functional Decline in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment
Patients with idiopathic pulmonary fibrosis (IPF) display an unpredictable and heterogeneous disease behaviour with a progressive functional decline…
1
Mins
14 Nov 2019
What Do Patients Want in an Asthma App?
Asthma is estimated to affect 300 million people worldwide,1 and the literature advocates the beneficial effect of self-management programmes…
1
Mins
14 Nov 2019
Lung and Eye Pathology Develop Concurrently in a Neonatal Supplemental Oxygen Model
Bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) are two severe disorders that arise…
1
Mins
14 Nov 2019
Obstructive Sleep Apnea and Objective Sleep Quality in Non-Dialysed Patients with Chronic Kidney Disease: An European Sleep Apnea Database (ESADA) Study
Short sleep duration and poor sleep quality have been reported in chronic kidney disease (CKD). Additionally, sleep disordered breathing (SDB)…
1
Mins
14 Nov 2019
Changes in Biomarkers in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib and Sildenafil
Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). Sildenafil is a phosphodiesterase-5…
2
Mins
14 Nov 2019
A Respiratory Review of Australian Men with Coal Mine Dust Lung Disease
In Queensland, Australia, coal mining is a large industry in terms of both employment and economy…
Loading posts...
« Previous
1
2
3
4
5
6
7
Next »